Patient Pavilion at Dartmouth Hitchcock Medical Center
Dartmouth Hitchcock Medical Center’s new birthing pavilion will launch a first-in-region drug treatment program targeting postpartum hemorrhage—a leading cause of maternal mortality—using the FDA-approved oxytocin analog carbetocin (Pabal). The initiative, ... Read More